Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 332

1.

Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease.

Tanaka M, Saito S, Inoue T, Satoh-Asahara N, Ihara M.

Int J Mol Sci. 2020 Mar 14;21(6). pii: E1992. doi: 10.3390/ijms21061992. Review.

2.

Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs.

Ihara M, Saito S.

J Alzheimers Dis. 2020 Mar 3. doi: 10.3233/JAD-200049. [Epub ahead of print]

PMID:
32144994
3.

The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy.

Owasil R, O'Neill R, Keable A, Nimmo J, MacGregor Sharp M, Kelly L, Saito S, Simpson JE, Weller RO, Smith C, Attems J, Wharton SB, Yuen HM, Carare RO.

Int J Mol Sci. 2020 Feb 12;21(4). pii: E1225. doi: 10.3390/ijms21041225.

4.

LidNA, a miRNA inhibitor constructed with unmodified DNA, requires an xxxA insertion sequence in miRNA binding site for its potent inhibitory activity.

Tachibana A, Saito S, Fujiyama Y, Tanabe T.

FEBS Lett. 2020 Feb 12. doi: 10.1002/1873-3468.13756. [Epub ahead of print]

PMID:
32052435
5.

Prolonged Myelosuppression due to Progressive Bone Marrow Fibrosis in a Patient with Acute Promyelocytic Leukemia.

Inagawa Y, Komeno Y, Saito S, Maenohara Y, Yamagishi T, Kawashima H, Saito T, Abe K, Iihara K, Hatada Y, Ryu T.

Case Rep Hematol. 2019 Nov 27;2019:1616237. doi: 10.1155/2019/1616237. eCollection 2019.

6.

Safety and efficacy of transvenous lead extractions for noninfectious superfluous leads in a Japanese population: A single-center experience.

Higuchi S, Shoda M, Saito S, Kanai M, Kataoka S, Yazaki K, Yagishita D, Ejima K, Hagiwara N.

Pacing Clin Electrophysiol. 2019 Dec;42(12):1517-1523. doi: 10.1111/pace.13806. Epub 2019 Sep 24.

PMID:
31531868
7.

[Drug Repositioning for Alzheimer's Disease].

Ihara M, Saito S.

Brain Nerve. 2019 Sep;71(9):961-970. doi: 10.11477/mf.1416201388. Japanese.

PMID:
31506398
8.

[Development of a Novel Treatment for Neurological Disorders by Drug Repositioning].

Saito S, Ihara M.

Brain Nerve. 2019 Sep;71(9):936-942. doi: 10.11477/mf.1416201385. Japanese.

PMID:
31506395
9.

Long-Term Clinical Outcomes of Cardiac Surgery for Kidney Transplant Patients.

Komagamine M, Nishinaka T, Ichihara Y, Saito S, Niinami H.

Ann Thorac Cardiovasc Surg. 2019 Aug 26. doi: 10.5761/atcs.oa.19-00192. [Epub ahead of print]

10.

[A case of spontaneous intracranial hypotension with transient neurological symptoms].

Sugiura M, Shibata K, Saito S, Nishimura Y, Takahashi K, Sakura H.

Rinsho Shinkeigaku. 2019 Aug 29;59(8):530-535. doi: 10.5692/clinicalneurol.cn-001298. Epub 2019 Jul 23. Japanese.

PMID:
31341129
11.

Effect of fingolimod on oligodendrocyte maturation under prolonged cerebral hypoperfusion.

Yasuda K, Maki T, Saito S, Yamamoto Y, Kinoshita H, Choi YK, Arumugam TV, Lim YA, Chen CLH, Wong PT, Ihara M, Takahashi R.

Brain Res. 2019 Oct 1;1720:146294. doi: 10.1016/j.brainres.2019.06.013. Epub 2019 Jun 12.

PMID:
31201815
12.

Association of genetic variants at 22q11.2 chromosomal region with cognitive performance in Japanese patients with schizophrenia.

Akiyama K, Saito A, Saito S, Ozeki Y, Watanabe T, Fujii K, Shimoda K.

Schizophr Res Cogn. 2019 Mar 26;17:100134. doi: 10.1016/j.scog.2019.100134. eCollection 2019 Sep.

13.

Development of a Multicomponent Intervention to Prevent Alzheimer's Disease.

Saito S, Yamamoto Y, Ihara M.

Front Neurol. 2019 May 8;10:490. doi: 10.3389/fneur.2019.00490. eCollection 2019. Review.

14.

The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice.

Nakaoku Y, Saito S, Yamamoto Y, Maki T, Takahashi R, Ihara M.

Int J Mol Sci. 2019 May 23;20(10). pii: E2539. doi: 10.3390/ijms20102539.

15.

Balloon-like Mobile Plaque in the Innominate Artery: Ultrasonographic and Pathological Perspectives of Repetitive Embolism.

Ikenouchi H, Washida K, Yoshimoto T, Fukuma K, Saito S, Inoue Y, Matsuda H, Ihara M.

J Stroke Cerebrovasc Dis. 2019 Jul;28(7):e95-e97. doi: 10.1016/j.jstrokecerebrovasdis.2019.04.015. Epub 2019 May 1.

PMID:
31053373
16.

Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives.

Tanaka M, Saito S, Inoue T, Satoh-Asahara N, Ihara M.

Int J Mol Sci. 2019 Apr 30;20(9). pii: E2139. doi: 10.3390/ijms20092139. Review.

17.

Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy.

Inoue T, Saito S, Tanaka M, Yamakage H, Kusakabe T, Shimatsu A, Ihara M, Satoh-Asahara N.

Proc Natl Acad Sci U S A. 2019 May 14;116(20):10031-10038. doi: 10.1073/pnas.1901659116. Epub 2019 Apr 29.

18.

Levofloxacin-associated Encephalopathy with Severe Hyperventilation.

Sugiura M, Shibata K, Saito S, Nishimura Y, Sakura H.

Intern Med. 2019 May 15;58(10):1495-1499. doi: 10.2169/internalmedicine.1619-18. Epub 2019 Feb 1.

19.

[A Case of Choriocarcinoma of the Small Intestine with Multiple Lung and Liver Metastases].

Watanabe A, Fukunari H, Aoki M, Saito S, Shitara K, Hayashi T, Tani Y, Ajioka Y.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2102-2104. Japanese.

PMID:
30692298
20.

Moyamoya Disease Susceptibility Variant RNF213 p.R4810K Increases the Risk of Ischemic Stroke Attributable to Large-Artery Atherosclerosis.

Okazaki S, Morimoto T, Kamatani Y, Kamimura T, Kobayashi H, Harada K, Tomita T, Higashiyama A, Takahashi JC, Nakagawara J, Koga M, Toyoda K, Washida K, Saito S, Takahashi A, Hirata M, Matsuda K, Mochizuki H, Chong M, Paré G, O'Donnell M, Ago T, Hata J, Ninomiya T, Dichgans M, Debette S, Kubo M, Koizumi A, Ihara M.

Circulation. 2019 Jan 8;139(2):295-298. doi: 10.1161/CIRCULATIONAHA.118.038439. No abstract available.

PMID:
30615506

Supplemental Content

Loading ...
Support Center